Participated · Seed · Aug 2026

Manna Coffee operates a network of autonomous coffee kiosks supported by an AI-driven Platform-as-a-Service that handles telemetry, payment reconciliation, restocking logistics and service coordination. In 2026 it launched the Manna Co:llective digital twin, a multi-agent system that coordinates operations across the network. The company offers co-branding and white-label tiers that let operators and brands open autonomous coffee points without building the underlying technology. Leadership says a network of roughly 20 well-performing kiosks averaging 25 cups per day could generate around $350,000–$400,000 in annual kiosk-level operating profit, though results depend on location performance and costs. Manna is focused on expanding deployment capacity and its qualified location pipeline, aiming to activate more than 500 locations using the funds raised. The company has attracted a broad investor base while continuing to grow its platform and operator ecosystem.

Led · Equity · Mar 2026

Etherdyne Technologies develops the Ether Power Platform, a magnetic-resonance-based wireless power system that transmits energy within a defined three-dimensional Ether Power Zone to power multiple devices simultaneously. The system can deliver up to 100 watts of total power across a space roughly the size of a desk, countertop, or room, while individual receivers handle roughly 0.1 watt up to about 50 watts per device. Etherdyne plans to license the platform to device manufacturers and product makers to enable multi-device cordless environments. The company has built a portfolio of 44 granted patents and has obtained key regulatory approvals, including FCC and CE certifications. Etherdyne is based in Santa Clara, California, and recently completed its first public fundraising effort, raising more than $1.2 million from over 400 investors via a Reg CF campaign on StartEngine.

Led · Series A · Feb 2025

Atombeam develops a technology it calls Data-as-Codewords, which uses cryptography and compression to translate data into codewords within an AI/ML-created codebook. Customers send and store those codewords along an event path and access data through the same codebook in its transformed state. According to the company, Data-as-Codewords is always compressed, always encrypted, and transmits without latency, optimizing transmission and storage. Atombeam offers products named Neurpac and Neurcom and plans to use new funding to further develop those products. The company is led by CEO Charles Yeomans and is based in Moraga, California. Its financing history includes the newly announced round that brings total funding to $35M. AtomBeam develops data compaction software aimed at improving data transmission with a focus on IoT connectivity. The company is led by CEO Charles Yeomans and is based in Moraga, CA. Recently AtomBeam ran a crowdfunding campaign that surpassed its $3M goal. The company plans to use the funds to continue growth, support further research and development, expand partnerships, and scale operations. The article does not disclose additional operating metrics or prior financing details.

Led · Equity · Feb 2024

Choose Your Horizon operates a proprietary telehealth platform that connects clinicians with patients for at-home ketamine treatments targeting depression, anxiety and PTSD. Its platform incorporates integration work and guided sessions before and during treatment. The company reports its telehealth platform has facilitated thousands of successful, safe treatments for more than 1,800 patients, with 98% reporting symptom improvement. In its first equity fundraising campaign on StartEngine the company raised over $580,000 from nearly 320 investors in 12 weeks, including $100,000 invested in the first five days. Investors include entrepreneurs Mike Mumola and Luis Berruga, as well as medical professionals, patients and individuals connected to the company. Choose Your Horizon says it will use the equity to expand toward nationwide coverage and aims to enter all 50 states by the end of 2024; it has also expanded its Medical Advisory Team and established an Integration Team.

Led · Equity · Jun 2023

iHealthScreen develops an AI-driven, integrated retinal imaging system designed for screening age-related macular degeneration (AMD), diabetic retinopathy (DR) and glaucoma. The company highlights that its systems can be used outside hospitals and incorporated into primary care facilities to improve access and reduce screening costs. iHealthScreen has received CE certification as well as Australian and UAE health approvals for AMD, DR and glaucoma screening. It reports existing customers and international traction with contracts in the U.S., E.U., Bangladesh and the UAE and a collaboration with Global Victoria in Australia. The company holds one U.S. patent for late AMD prediction, has one patent pending and four provisional patent applications, and is working to secure additional research grants. On the financing side, iHealthScreen has raised seed capital and received NIH funding to support development and research.